Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency
about
FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathwayRho GTPases in hematopoiesis and hemopathiesDOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxisThe molecular pathology of primary immunodeficienciesGenetic disorders coupled to ROS deficiencyCongenital defects in neutrophil dynamicsActin cytoskeletal defects in immunodeficiencyLeukocyte migration from a fish eye's viewThe RHO-1 RhoGTPase modulates fertility and multiple behaviors in adult C. elegansFlow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary ImmunodeficienciesNADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic protein 1 in lymphopoiesis and innate immunityCul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesisA regulated adaptor function of p40phox: distinct p67phox membrane targeting by p40phox and by p47phox.The Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment.Mammalian target of rapamycin and Rictor control neutrophil chemotaxis by regulating Rac/Cdc42 activity and the actin cytoskeletonActivation of the A(3) adenosine receptor inhibits fMLP-induced Rac activation in mouse bone marrow neutrophils.Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis.Acute progression of BCR-FGFR1 induced murine B-lympho/myeloproliferative disorder suggests involvement of lineages at the pro-B cell stage.Purinergic regulation of neutrophil chemotaxis.Rac2-deficiency leads to exacerbated and protracted colitis in response to Citrobacter rodentium infectionNeutrophil functions and autoimmune arthritis in the absence of p190RhoGAP: generation and analysis of a novel null mutation in mice.Dysregulated signaling pathways in the development of CNTRL-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models.Proinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signaling.Agonist activation of f-actin-mediated eosinophil shape change and mediator release is dependent on Rac2.Role of p47phox in antigen-presenting cell-mediated regulation of humoral immunity in mice.Dual roles for Rac2 in neutrophil motility and active retention in zebrafish hematopoietic tissue.RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency.Mice deficient in the ALS2 gene exhibit lymphopenia and abnormal hematopietic function.Vav proteins control MyD88-dependent oxidative burst.The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems.CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism.The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease.Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton.Rac signaling in breast cancer: a tale of GEFs and GAPs.Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization.Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cellsHem-1: putting the "WAVE" into actin polymerization during an immune response.Neutrophil-mediated oxidative burst and host defense are controlled by a Vav-PLCgamma2 signaling axis in miceNeutrophils in host defense: new insights from zebrafish.
P2860
Q24301340-F91DA86C-331C-48EC-83C2-478434A9F9CDQ24652636-EA91CBAD-39D2-41D1-887A-0CFB48784812Q24683000-A1AC31AE-6140-4615-A3D9-2A1B22C0E8C9Q24685932-0411C7C9-0C11-4165-8924-F9577CAC9F32Q26799545-31F37F0B-8D3C-495E-874A-258E6EC4F88AQ26996029-AB40D36B-9B35-4E7B-86D8-92934F8EDA70Q27021852-24A80817-006A-4720-9D78-8EDC1E6FAC60Q27025000-46A67B51-E4F0-4112-A0D6-ACEBFC1D1601Q27350466-BCEEA931-65FA-42D8-9408-08CE4755F5F7Q28076919-6114604C-E6EB-424B-8D2B-C9F4C155AF77Q28247419-C5D1C97C-6F29-4A00-B17C-ECAD9D6E52C1Q28506215-B2D82AD0-B6D4-412B-8B3B-AC0952CE8892Q28593723-F677A5E2-838A-46AD-BC83-EDAAECF2E3AEQ30478913-7198CAC3-6D60-42FA-ACE2-1478CB4950C2Q30538230-32D1C2AA-28B4-4E02-B3F1-54F3E79ACB49Q30555996-EC567901-3466-4800-861A-47F03AD27F80Q33759296-5ED3FCAE-05F9-44E2-8EE0-84CC99B02B5CQ34236833-3E6AB812-4970-4C5C-AD9E-43637BF3A7D4Q34305360-BD5BA521-20A2-49BC-8FE0-BAC32A406095Q34425713-E04AB8FA-99D5-4CC9-9809-C59907C34291Q34684714-CEEB2520-A2A0-47F5-868D-9EB5D67A9CF1Q34724992-25448890-7C91-4595-878D-63DD3238356BQ34777511-2E8FBDB0-A738-46B5-B7E3-3674221C4853Q34795130-F36C00F6-162E-43D6-8453-2E5BD0A0F5CFQ35016132-04708D9B-2792-4B09-A613-B1A625677073Q35072741-0D872D91-AD34-4F33-B742-B035FBBBF8AAQ35421334-6B7DF0DD-9492-4FF4-9022-46C5E25AB335Q35589474-6536A67A-4287-4A31-AEE7-8357CD0275C3Q35633071-B4971C2D-E4C0-460F-B71C-2DEB49FA7C9DQ35751091-0BF6BF04-F3B9-4F2E-B6CD-947EA6198EB4Q35828194-A4D5E43C-D0DE-494B-AAED-B4A7DDF58548Q35847956-7002D9B8-D4EA-4FD5-AE37-B3403BEDEA1BQ35848279-02E0C457-B15C-4317-9B07-AFA3FC8BB1DDQ35848885-9ABBBC6D-2B18-417B-A0A0-9184A50CD0A1Q35854151-BA044E04-EDCF-4898-B57A-763FEE59EAADQ35888155-9FD5B727-7FC8-4CA9-908B-FC15174EECDEQ35976605-37E5626C-4892-46FC-AD9C-F0C08D678B52Q35998040-5440D5A0-030A-41BD-A537-4C9F0EFD6EDDQ36025303-A59A9164-EB13-45BD-8591-9D85054B423CQ36057930-22FA7744-29E1-46BA-9313-DED95C1A1C46
P2860
Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Dominant negative mutation of ...... man phagocyte immunodeficiency
@ast
Dominant negative mutation of ...... man phagocyte immunodeficiency
@en
Dominant negative mutation of ...... man phagocyte immunodeficiency
@nl
type
label
Dominant negative mutation of ...... man phagocyte immunodeficiency
@ast
Dominant negative mutation of ...... man phagocyte immunodeficiency
@en
Dominant negative mutation of ...... man phagocyte immunodeficiency
@nl
prefLabel
Dominant negative mutation of ...... man phagocyte immunodeficiency
@ast
Dominant negative mutation of ...... man phagocyte immunodeficiency
@en
Dominant negative mutation of ...... man phagocyte immunodeficiency
@nl
P2093
P1433
P1476
Dominant negative mutation of ...... man phagocyte immunodeficiency
@en
P2093
B Petryniak
C W Derrow
D A Williams
D R Ambruso
J E Levine
P304
P407
P577
2000-09-01T00:00:00Z